|
WO2014117121A1
(en)
|
2013-01-28 |
2014-07-31 |
St. Jude Children's Research Hospital, Inc. |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
CN112877291A
(zh)
|
2014-04-10 |
2021-06-01 |
西雅图儿童医院 (Dba西雅图儿童研究所) |
基因修饰的t细胞产品、其制备方法和用途
|
|
KR20210014210A
(ko)
|
2014-05-15 |
2021-02-08 |
내셔널 유니버시티 오브 싱가포르 |
변형된 천연 살해 세포 및 그의 용도
|
|
WO2016011210A2
(en)
|
2014-07-15 |
2016-01-21 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
|
US10174095B2
(en)
|
2014-07-21 |
2019-01-08 |
Novartis Ag |
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
|
|
SG10201913765YA
(en)
|
2014-07-21 |
2020-03-30 |
Novartis Ag |
Treatment of cancer using a cd33 chimeric antigen receptor
|
|
WO2016042461A1
(en)
|
2014-09-15 |
2016-03-24 |
Molmed Spa |
Chimeric antigen receptors
|
|
MX2017004603A
(es)
*
|
2014-10-07 |
2017-06-30 |
Cellectis |
Metodo para modular actividad de celulas inmunes inducidas por car.
|
|
WO2016073602A2
(en)
*
|
2014-11-05 |
2016-05-12 |
Juno Therapeutics, Inc. |
Methods for transduction and cell processing
|
|
PT3560953T
(pt)
|
2014-12-24 |
2024-03-26 |
Autolus Ltd |
Célula
|
|
US11596652B2
(en)
|
2015-02-18 |
2023-03-07 |
Enlivex Therapeutics R&D Ltd |
Early apoptotic cells for use in treating sepsis
|
|
US11512289B2
(en)
|
2015-02-18 |
2022-11-29 |
Enlivex Therapeutics Rdo Ltd |
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
US11497767B2
(en)
|
2015-02-18 |
2022-11-15 |
Enlivex Therapeutics R&D Ltd |
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
US11318163B2
(en)
|
2015-02-18 |
2022-05-03 |
Enlivex Therapeutics Ltd |
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
US11000548B2
(en)
|
2015-02-18 |
2021-05-11 |
Enlivex Therapeutics Ltd |
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
US11304976B2
(en)
|
2015-02-18 |
2022-04-19 |
Enlivex Therapeutics Ltd |
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
KR102606190B1
(ko)
|
2015-02-20 |
2023-11-23 |
오하이오 스테이트 이노베이션 파운데이션 |
Nkg2d 및 종양 연관 항원에 대해 유도된 이가 항체
|
|
EP3268014B1
(en)
*
|
2015-03-10 |
2022-09-21 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
T-cell receptors directed against the preferentially expressed antigen of melanoma and uses thereof
|
|
JP6879932B2
(ja)
*
|
2015-04-06 |
2021-06-02 |
サイトイミューン セラピューティクス， インコーポレイテッドＣｙｔｏｉｍｍｕｎｅ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｌｌｃ |
神経膠芽腫のためのｅｇｆｒ指向ｃａｒ療法
|
|
IL303972A
(en)
|
2015-04-08 |
2023-08-01 |
Novartis Ag |
CD20 treatments, CD22 treatments and combined treatments with CD19 chimeric antigen receptor expressing cell
|
|
CN107710751B
(zh)
*
|
2015-04-17 |
2020-01-10 |
三菱电机株式会社 |
显示控制装置、显示系统及显示控制方法
|
|
WO2016168595A1
(en)
|
2015-04-17 |
2016-10-20 |
Barrett David Maxwell |
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
|
|
EP4140492A1
(en)
|
2015-04-21 |
2023-03-01 |
Enlivex Therapeutics Rdo Ltd |
Therapeutic pooled blood apoptotic cell preparations and uses thereof
|
|
JP7245647B2
(ja)
*
|
2015-07-15 |
2023-03-24 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法用の操作された細胞
|
|
AU2016297014B2
(en)
*
|
2015-07-21 |
2021-06-17 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
|
HK1256087A1
(zh)
|
2015-08-07 |
2019-09-13 |
Seattle Children's Hospital, Dba Seattle Children's Research Institute |
用於实体瘤靶向的双特异性cart细胞
|
|
KR20180053744A
(ko)
*
|
2015-09-23 |
2018-05-23 |
사이토이뮨 테라퓨틱스 엘엘씨 |
면역 요법을 위한 flt3 유도된 car 세포
|
|
IL259576B
(en)
|
2015-12-04 |
2022-09-01 |
Novartis Ag |
grna molecule containing tracr and crrna, pharmaceutical composition containing it and method for preparing cells for immunotherapy
|
|
AU2017207936A1
(en)
*
|
2016-01-15 |
2018-07-26 |
Etubics Corporation |
Methods and compositions for T-cell immunotherapy
|
|
WO2017130223A2
(en)
|
2016-01-29 |
2017-08-03 |
Virocan Therapeutics Pvt. Ltd. |
A chimeric antigen receptor specific to b-cell maturation antigen, a recombinant expression vector and a method thereof
|
|
JP6884155B2
(ja)
*
|
2016-02-18 |
2021-06-09 |
エンリヴェックス セラピューティクス リミテッド |
癌治療のための併用免疫療法及びサイトカイン制御療法
|
|
CN109069537B
(zh)
*
|
2016-04-04 |
2022-04-15 |
亘喜生物科技（上海）有限公司 |
共刺激结构域中具有重复结合基序的car
|
|
WO2017178586A1
(en)
*
|
2016-04-15 |
2017-10-19 |
Cellectis |
A method of engineering prodrug-specific hypersensitive t-cells for immunotherapy by gene expression
|
|
WO2017178585A1
(en)
|
2016-04-15 |
2017-10-19 |
Cellectis |
A method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation
|
|
MY200337A
(en)
|
2016-10-07 |
2023-12-20 |
Novartis Ag |
Nucleic acid molecules encoding chimeric antigen receptors comprising a cd20 binding domain
|
|
EP3544996A2
(en)
*
|
2016-11-22 |
2019-10-02 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2018102795A2
(en)
|
2016-12-02 |
2018-06-07 |
University Of Southern California |
Synthetic immune receptors and methods of use thereof
|
|
US10799536B2
(en)
|
2016-12-09 |
2020-10-13 |
Onk Therapeutics Limited |
Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38
|
|
US11408005B2
(en)
|
2016-12-12 |
2022-08-09 |
Seattle Children's Hospital |
Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
|
|
CA3054621A1
(en)
|
2017-03-22 |
2018-09-27 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
AU2018245749A1
(en)
|
2017-03-27 |
2019-10-03 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
CA3056439A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Truncated nkg2d chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
CN107164412B
(zh)
*
|
2017-06-30 |
2020-10-23 |
山东兴瑞生物科技有限公司 |
一种安全型抗cea嵌合抗原受体修饰t细胞的制备方法及其应用
|
|
EP3720882A4
(en)
*
|
2017-12-05 |
2021-10-27 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
T-CELLS WITH TWO DIFFERENT CHIMERIC ANTIGEN RECEPTORS AND THEIR USE
|
|
IL316570A
(en)
*
|
2017-12-05 |
2024-12-01 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
T cells containing chimeric receptors for CD138 and CD38 antigens and their use
|
|
SG11202007156QA
(en)
|
2018-02-09 |
2020-08-28 |
Nat Univ Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
JP7438988B2
(ja)
|
2018-06-13 |
2024-02-27 |
ノバルティス アーゲー |
Ｂｃｍａキメラ抗原受容体及びその使用
|
|
US12486514B2
(en)
|
2018-08-29 |
2025-12-02 |
National University Of Singapore |
Method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
WO2020160217A1
(en)
*
|
2019-02-01 |
2020-08-06 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Microenvironment sensors to regulate engineered gene expression
|
|
GB201902277D0
(en)
*
|
2019-02-19 |
2019-04-03 |
King S College London |
Therapeutic agents
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
US11969443B2
(en)
|
2019-03-06 |
2024-04-30 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with self-driving chimeric antigen receptors
|
|
CN111686128A
(zh)
*
|
2019-03-12 |
2020-09-22 |
重庆精准生物技术有限公司 |
一种缺氧可调控的启动子在car-t中的应用
|
|
EP3922721A4
(en)
*
|
2019-03-12 |
2023-01-11 |
Chongqing Precision Biotech Company Limited |
PROMOTER REGULATED BY HYPOXIA AND ITS APPLICATION
|
|
IL292924A
(en)
|
2019-11-26 |
2022-07-01 |
Novartis Ag |
Chimeric antigen receptors cd19 and cd22 and their uses
|
|
AU2020397189A1
(en)
*
|
2019-12-05 |
2022-07-14 |
Vycellix, Inc. |
Modulators of the immune escape mechanism for universal cell therapy
|
|
WO2022072990A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Baylor College Of Medicine |
Cytotoxic and costimulatory chimeric antigen receptors
|
|
AU2022270361A1
(en)
|
2021-05-05 |
2023-11-16 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
|
NL2037811B1
(en)
|
2024-05-29 |
2025-12-12 |
Univ Oslo |
Treatment for Cancer
|
|
NL2037929B1
(en)
|
2024-06-11 |
2026-01-12 |
Prinses Maxima Centrum Voor Kinderoncologie B V |
Brain Organoid
|